NCT06433401 The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease
| NCT ID | NCT06433401 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Yildirim Beyazıt University |
| Condition | Congenital Heart Disease in Adolescence |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-08-29 |
| Primary Completion | 2025-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-08-29 with a primary completion date of 2025-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Congenital heart disease is one of the most common congenital defects with a high mortality and morbidity rate. Children with congenital heart disease step from pediatric care to adult care during adolescence. This situation has brought up transitional care, which is defined as "the purposeful and planned movement of adolescents and young adults with chronic physical and medical conditions from pediatric to adult-oriented health systems". Since adolescents with congenital heart disease are at high risk for complications in adulthood, it is very important to raise awareness, increase the level of readiness for adult care and gain self-management skills during the transition phase. This study was planned as a randomized controlled experimental study to evaluate the effect of the developmental transition care model applied to adolescents with congenital heart disease during the transition from pediatric care to adult care on the transition readiness level, self-management skills and care satisfaction of adolescents. Studies have shown that both adolescents with congenital heart disease and their caregivers need professional support, appropriate transition education and care before transition to adult care in order to increase adaptation to adult care, to gain self-management skills and to reduce their concerns. Studies in which adolescents are followed up after transition to adult care show that when the transition process is not successfully completed, there is excessive time between the last pediatric control and the first adult control or there are losses in further follow-up. Although there are studies in our country in which transition care is applied, this study is planned because there is no intervention study in which developmental transition care model is applied to adolescents with congenital heart disease. It is thought that this study will increase the transition readiness levels, self-management skills and care satisfaction of adolescents with congenital heart disease and guide the nurses working with them.
Eligibility Criteria
Inclusion Criteria: * Voluntarily agree to participate in the research * To be between the ages of 16-20, * Having a diagnosis of congenital heart disease, * Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted, * To be able to communicate in Turkish, * Not having any mental deficiency that may prevent communication Exclusion Criteria: * Refusing to participate in the research, * Not being able to communicate in Turkish, * Not showing up regularly for follow-ups, * Having any mental disability that may prevent communication
Contact & Investigator
Tutku KIRÇI TEMİZ, PhD s.
PRINCIPAL INVESTIGATOR
Ankara Yildirim Beyazıt University
Frequently Asked Questions
Who can join the NCT06433401 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 20 Years, studying Congenital Heart Disease in Adolescence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06433401 currently recruiting?
Yes, NCT06433401 is actively recruiting participants. Contact the research team at tutkukrc29095@gmail.com for enrollment information.
Where is the NCT06433401 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06433401 clinical trial?
NCT06433401 is sponsored by Ankara Yildirim Beyazıt University. The principal investigator is Tutku KIRÇI TEMİZ, PhD s. at Ankara Yildirim Beyazıt University. The trial plans to enroll 70 participants.